Acute stroke trials: strengthening the underpowered.
Furlan
Anthony J
AJ
D000208:Acute Disease; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic / Q000592:standards; D018849:Controlled Clinical Trials as Topic / Q000592:standards; D003362:Cost-Benefit Analysis; D023381:Endpoint Determination; D006801:Humans; D018696:Neuroprotective Agents / Q000191:economics / Q000627:therapeutic use*; D012107:Research Design; D018570:Risk Assessment; D018401:Sample Size; D020521:Stroke / Q000145:classification / Q000188:drug therapy* / Q000517:prevention & control
D000925:Anticoagulants; D018696:Neuroprotective Agents